Younes, A., Oki, Y., Bociek, R. G., Kuruvilla, J., Fanale, M., Neelapu, S., . . . Martell, R. E. (2011). Phase II Study of Mocetinostat (MGCD0103) In Patients with Relapsed and Refractory Classical Hodgkin Lymphoma. Lancet Oncol.
Citación estilo ChicagoYounes, Anas, et al. "Phase II Study of Mocetinostat (MGCD0103) In Patients With Relapsed and Refractory Classical Hodgkin Lymphoma." Lancet Oncol 2011.
Cita MLAYounes, Anas, et al. "Phase II Study of Mocetinostat (MGCD0103) In Patients With Relapsed and Refractory Classical Hodgkin Lymphoma." Lancet Oncol 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.